0000925421-17-000365.txt : 20170925
0000925421-17-000365.hdr.sgml : 20170925
20170925173017
ACCESSION NUMBER: 0000925421-17-000365
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170922
FILED AS OF DATE: 20170925
DATE AS OF CHANGE: 20170925
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROSSI DINO A
CENTRAL INDEX KEY: 0001209059
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38210
FILM NUMBER: 171100545
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Krystal Biotech, Inc.
CENTRAL INDEX KEY: 0001711279
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 810930882
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2100 WHARTON STREET
STREET 2: SUITE 701
CITY: PITTSBURGH
STATE: PA
ZIP: 15203
BUSINESS PHONE: (412) 586-5830
MAIL ADDRESS:
STREET 1: 2100 WHARTON STREET
STREET 2: SUITE 701
CITY: PITTSBURGH
STATE: PA
ZIP: 15203
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2017-09-22
0001711279
Krystal Biotech, Inc.
KRYS
0001209059
ROSSI DINO A
C/O KRYSTAL BIOTECH, INC.
2100 WHARTON STREET, SUITE 701
PITTSBURGH
PA
15203
1
0
0
0
Common Stock
2017-09-22
4
C
0
123691
A
123691
D
Series A Convertible Preferred Stock
2017-09-22
4
C
0
123691
0
D
Common Stock
123691
0
D
Stock Option (Right to Buy)
8.79
2021-06-01
2027-06-01
Common Stock
18949
18949
D
The Series A convertible preferred stock converted on a one-to-one basis into 123,691 shares of common stock upon the closing of Krystal Biotech, Inc.'s initial public offering.
/s/ Katherine A. Shaia, as attorney-in-fact for Dino A. Rossi
2017-09-25